Tech Company Financing Transactions
Diagnovus Funding Round
TriStar Technology Fund and private investors participated in a $1.5 million funding round for Diagnovus. The round was announced on 12/31/2013.
Transaction Overview
Company Name
Announced On
12/31/2013
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Investors
TriStar Technology Fund (Brian Laden)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
336 Hill Ave. 302
Nashville, TN 37210
USA
Nashville, TN 37210
USA
Phone
Website
Email Address
Overview
Founded in 2011 and based in Nashville, TN, Diagnovus's mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects.
Management Team
Browse more venture capital transactions:
Prev: 12/31/2013: Super Evil Mega venture capital transaction
Next: 12/31/2013: Filament Labs venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs